183 related articles for article (PubMed ID: 26125663)
21. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
[TBL] [Abstract][Full Text] [Related]
22. [The role of miRNAs in the pathogenesis of pituitary adenomas].
Németh K; Darvasi O; Szücs N; Czirják S; Butz H
Orv Hetil; 2018 Feb; 159(7):252-259. PubMed ID: 29429349
[TBL] [Abstract][Full Text] [Related]
23. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
[TBL] [Abstract][Full Text] [Related]
25. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression.
Bai X; Wang W; Zhao P; Wen J; Guo X; Shen T; Shen J; Yang X
Carcinogenesis; 2020 Mar; 41(1):111-121. PubMed ID: 31605132
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs: Suggested role in pituitary adenoma pathogenesis.
Gadelha MR; Kasuki L; Dénes J; Trivellin G; Korbonits M
J Endocrinol Invest; 2013 Nov; 36(10):889-95. PubMed ID: 24317305
[TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
[TBL] [Abstract][Full Text] [Related]
28. RPSAP52 lncRNA Inhibits p21Waf1/CIP Expression by Interacting With the RNA Binding Protein HuR.
D'Angelo D; Arra C; Fusco A
Oncol Res; 2020 Mar; 28(2):191-201. PubMed ID: 31831098
[TBL] [Abstract][Full Text] [Related]
29. Analysis of pituitary hormones and chromogranin A mRNAs in null cell adenomas, oncocytomas, and gonadotroph adenomas by in situ hybridization.
Lloyd RV; Jin L; Fields K; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
Am J Pathol; 1991 Sep; 139(3):553-64. PubMed ID: 1653518
[TBL] [Abstract][Full Text] [Related]
30. Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo.
Dai L; Wang W; Zhang S; Jiang Q; Wang R; Dai L; Cheng L; Yang Y; Wei YQ; Deng HX
Cell Biol Int; 2012 Aug; 36(8):765-70. PubMed ID: 22574716
[TBL] [Abstract][Full Text] [Related]
31. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
[TBL] [Abstract][Full Text] [Related]
32. miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cδ.
Gentilin E; Tagliati F; Filieri C; Molè D; Minoia M; Rosaria Ambrosio M; Degli Uberti EC; Zatelli MC
Endocrinology; 2013 May; 154(5):1690-700. PubMed ID: 23525216
[TBL] [Abstract][Full Text] [Related]
33. Strategies to use microRNAs as therapeutic targets.
Gentilin E; Degli Uberti E; Zatelli MC
Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):629-639. PubMed ID: 27923456
[TBL] [Abstract][Full Text] [Related]
34. The GnRH receptor gene is preferentially expressed in functioning gonadotroph adenomas and displays a Mae III polymorphism site.
Kottler ML; Seret-Bégué D; Lahlou N; Assayag M; Carré MC; Lagarde JP; Ajzenberg C; Christin-Maitre S; Bouchard P; Mikol J; Counis R; Warnet A
Clin Endocrinol (Oxf); 1998 Jul; 49(1):115-23. PubMed ID: 9797855
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of Cyclin B1 by miRNA and its implications in cancer.
Huang V; Place RF; Portnoy V; Wang J; Qi Z; Jia Z; Yu A; Shuman M; Yu J; Li LC
Nucleic Acids Res; 2012 Feb; 40(4):1695-707. PubMed ID: 22053081
[TBL] [Abstract][Full Text] [Related]
36. Decreased follistatin gene expression in gonadotroph adenomas.
Penabad JL; Bashey HM; Asa SL; Haddad G; Davis KD; Herbst AB; Gennarelli TA; Kaiser UB; Chin WW; Snyder PJ
J Clin Endocrinol Metab; 1996 Sep; 81(9):3397-403. PubMed ID: 8784103
[TBL] [Abstract][Full Text] [Related]
37. miR-15a and miR-16-1 down-regulation in pituitary adenomas.
Bottoni A; Piccin D; Tagliati F; Luchin A; Zatelli MC; degli Uberti EC
J Cell Physiol; 2005 Jul; 204(1):280-5. PubMed ID: 15648093
[TBL] [Abstract][Full Text] [Related]
38. Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas.
Butz H; Németh K; Czenke D; Likó I; Czirják S; Zivkovic V; Baghy K; Korbonits M; Kovalszky I; Igaz P; Rácz K; Patócs A
Pathol Oncol Res; 2017 Jul; 23(3):633-641. PubMed ID: 28004354
[TBL] [Abstract][Full Text] [Related]
39. MiR-448 targets BLC2 and inhibits the growth of pituitary adenoma cells.
He C; Yang J; Ding J; Li S; Wu H; Zhou F; Teng L; Yang J
Biochem Cell Biol; 2020 Aug; 98(4):511-517. PubMed ID: 32648768
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of glucose‑6‑phosphate dehydrogenase by microRNA‑1 inhibits the growth of pituitary tumor cells.
He C; Yang J; Ding J; Li S; Wu H; Xiong Y; Zhou F; Jiang Y; Teng L; Yang J
Oncol Rep; 2018 Dec; 40(6):3533-3542. PubMed ID: 30272333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
